title: Biotechnology. Singapore firm abandons plans for stem cell therapies.
authors.forename: Dennis
authors.initials: D
authors.lastname: Normile
mesh_terms: D001709:Biotechnology / Q000191:economics; D003920:Diabetes Mellitus / Q000628:therapy*; D033041:Embryo Research / Q000191:economics / Q000941:ethics; D053595:Embryonic Stem Cells; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D012109:Research Support as Topic; D012846:Singapore